Testing in vivo, in vitro, xenograft, orthotopic xenograft, syngeneic and cancer. Based on a more than 15 years experience, EPO offers customized and comprehensive service for the preclinical development of new cancer drugs.
Testing in vivo, in vitro, xenograft, orthotopic xenograft, syngeneic and cancer. Based on a more than 15 years experience, EPO offers customized and comprehensive service for the preclinical development of new cancer drugs.
Testing in vivo, in vitro, xenograft, orthotopic xenograft, syngeneic and cancer. Based on a more than 15 years experience, EPO offers customized and comprehensive service for the preclinical development of new cancer drugs.